The largest database of trusted experimental protocols

The B35130 is a laboratory equipment product manufactured by Thermo Fisher Scientific. It is a core piece of equipment with a primary function of performing specific laboratory tasks. The detailed specifications and intended use of this product are not available in this response.

Automatically generated - may contain errors

3 protocols using b35130

1

Cell Proliferation Analysis via EdU and BrdU

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells in culture were pulsed with EdU (10 μmol/L; C10643, Invitrogen) for 30 minutes. Plates were then washed and treated with 10 μmol/L of Ara-C for 12 hours, washed and released into growth media for the indicated periods of time. BrdU (10 μmol/L; B23151, Invitrogen) was added 30 minutes before harvesting. Trypsinized cells were fixed with 70% ethanol at 4°C overnight, incubated in 2 mol/L HCl solution for 30 minutes at room temperature (RT), and washed in 3% BSA in PBS. EdU was detected using Click-iT EdU AlexaFluor647 picolyl-azide toolkit (C10643, Invitrogen) according to the manufacturer's protocol. Next, cells were incubated with mouse anti-BrdU monoclonal antibody conjugated to Alexa Fluor 488 (1:20, B35130, Invitrogen) in antibody staining solution (1% BSA, 0.2% Tween-20 in PBS) for 1 hour at room temperature. After washing in PBS, cells were incubated with DAPI and analyzed by flow cytometry.
+ Open protocol
+ Expand
2

Ischemic Brain Tissue Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Animals were euthanized 2 weeks after ischemic onset. Brains were quickly removed and frozen, and coronal sections of 20 μm thickness were prepared. Infarction volumes were quantified on Nissl-stained sections using the “indirect” morphometric method with Image J software. Immunohistochemistry was performed as described before (Esposito et al., 2013 (link)) using primary antibodies anti-Doublecortin (DCX) (1:100, #18723 Abcam) and anti- BrdU (1:200, B35130 Invitrogen) as a marker of neurogenesis, and anti-type IV Collagen (1,10, #1340–01 SouthernBiotech) for vascular remodeling and anti-Ki67 (1,500, #1667 Abcam), as proliferation marker, for detecting angiogenesis. GFAP (1,200, #130300 Invitrogen), as a marker of astrocytes, PDGFβ (1,200, #AF1042 R&D systems), as marker of pericytes, Iba1(1,200, #019–19,741 WAKO or Abcam 5,076), as marker of microglia, or NeuN (1,200, #MAB377 Millipore) as marker of neurons, were co-stained with BDNF (1,200, # ab46176 Abcam) or VEGF (1,50, #sc152 Santa Cruz). Three nonoverlapping areas (0.125 mm2 per area) were chosen in the boundary zone of the ischemic core to analyze the peri-infarct area.
+ Open protocol
+ Expand
3

Dual-Labeling Cell Cycle Progression

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells grown in YES were synchronized in G1 phase and released in the presence of 10 µM EdU. After the first S phase, EdU was removed by washing the cells three times with equal volumes of YES. Before the second S phase 50 µM BrdU was added and kept in the medium until the second S phase was completed. After adding the analogue the cells were incubated in the dark until they were fixed. Cell fixation, zymolase- and HCl-treatment and blocking were as described above. EdU detection was then performed as described above. Primary antibody against BrdU (Invitrogen cat # B-35130, MoBU1) was used at a dilution of 1∶20 and the cells were incubated overnight at 4°C on a rotating wheel. The next day, the cells were washed 3 times with PBS, 2% FCS and 0.05% Tween-20. Secondary anti-mouse IgG1:FITC (AbD Serotec cat.# STAR132F) was added at a dilution of 1∶250. After incubation for 2 hours at room temperature, the cells were washed 3 times with PBS, 2% FCS and 0.05% Tween-20. The cells were mounted and viewed as above.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!